e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Clinical markers of asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
SABA overuse in the Portuguese prescription database
A. Sá-Sousa (Porto, Portugal), R. Almeida (Porto, Portugal), A. Freitas (Porto, Portugal), J. Almeida Fonseca (Porto, Portugal)
Source:
International Congress 2018 – Clinical markers of asthma
Session:
Clinical markers of asthma
Session type:
Thematic Poster
Number:
4002
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Sá-Sousa (Porto, Portugal), R. Almeida (Porto, Portugal), A. Freitas (Porto, Portugal), J. Almeida Fonseca (Porto, Portugal). SABA overuse in the Portuguese prescription database. 4002
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Predictors of excessive short-acting beta2-agonist use and asthma exacerbations: a retrospective analysis of a Polish prescription database.
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
Data-driven prescription patterns in patients under maintenance treatment for respiratory diseases from the Portuguese prescription database
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019
Late Breaking Abstract - Impact of maintenance and reliever therapy (MART)-focused asthma guideline on SABA prescriptions
Source: Virtual Congress 2021 – Highlights for primary care in 2021
Year: 2021
Identification of asthma level of control using administrative data of short-acting beta-agonist inhalers purchase
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
The use of electronic alerts in primary care to identify the over-prescription of short-acting beta2-agonists in people with asthma: a systematic review
Source: International Congress 2017 – Primary care management of asthma and COPD
Year: 2017
Overuse of short-acting beta-agonists (SABA) and risk factors among patients with asthma
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020
Changes in inhaled anticholinergic prescription pattern in a Spanish health department
Source: Annual Congress 2007 - Respiratory issues in primary care
Year: 2007
Suboptimal asthma control among over-the-counter reliever purchasers in the community pharmacy.
Source: International Congress 2019 – Epidemiology of airway diseases in primary care
Year: 2019
ICS-formoterol reliever
versus
ICS and short-acting ß
2
-agonist reliever in asthma: a systematic review and meta-analysis
Source: ERJ Open Res, 7 (1) 00701-2020; 10.1183/23120541.00701-2020
Year: 2021
An electronic alert to reduce excessive prescribing of short-acting beta2-agonists for people with asthma in East London: a retrospective case-control study using routine primary care data
Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine
Year: 2020
SABA overreliance and physician visits in Canada
Source: Virtual Congress 2020 – Diagnosis and management of asthma
Year: 2020
SABA and ICS use among mild asthma patients in UK primary care
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019
Effect of combined inhaled corticosteroid-formoterol therapy on short-acting beta2-agonist use in Poland: a retrospective analysis of pharmacy reports
Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma
Year: 2020
Use of short-acting beta-2 agonists (SABA) and exacerbations in a nationwide Swedish asthma cohort (HERA)
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019
Late Breaking Abstract - Overestimation of asthma control and misperception of short-acting ß2-agonists (SABA) use among physicians in Poland
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020
Inappropriate overuse of inhaled corticosteroids in patients with moderate COPD in UK primary care
Source: Annual Congress 2011 - Disease management in specific primary care populations
Year: 2011
The beliefs about medication questionnaire and adherence in users of inhaled corticosteroids
Source: Eur Respir J 2006; 28: Suppl. 50, 572s
Year: 2006
The drug costs associated with COPD prescription medicine in Denmark
Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management
Year: 2012
Trends of short-acting beta-agonist (SABA) surrounding days of high use in asthma and COPD
Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases
Year: 2019
Treatable traits as predictors of SABA overuse in the community.
Source: International Congress 2019 – Epidemiology of airway diseases in primary care
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept